breast Cancer

mRNA Technology: Vaccines and Beyond

Dr Raolat Abdulai

Fourth quarter and full year 2021 results

Fourth quarter and full-year 2021 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session


Our commitment to fight COVID-19

Throughout the ongoing pandemic, Sanofi has joined forces to fight COVID-19 in every way possible

World Polio Day

From Wearables to "Invisibles"

We're making it easier to participate in clinical trials from home. Find out how wireless technology can help us understand the impact of itch on sleeping children

2020 integrated report

Sanofi’s Rare Humanitarian Program Turns 30

“Our purpose is clear–to help ensure that people living with rare diseases around the world have the ability to access the treatments they need” -Paul Hudson, Chief Executive Officer

Diversity at Sanofi

Join us!

You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives

  • Camera
    Press releases
    2022-01-19MMMM DD YYYY
    Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis